Extracellular vesicle‐mediated delivery of circDYM alleviates CUS‐induced depressive‐like behaviours
X Yu, Y Bai, B Han, M Ju, T Tang… - Journal of …, 2022 - Wiley Online Library
Major depressive disorder (MDD) is the most prevalent psychiatric disorder worldwide and
severely limits psychosocial function and quality of life, but no effective medication is …
severely limits psychosocial function and quality of life, but no effective medication is …
Gene losses in the common vampire bat illuminate molecular adaptations to blood feeding
Vampire bats are the only mammals that feed exclusively on blood. To uncover genomic
changes associated with this dietary adaptation, we generated a haplotype-resolved …
changes associated with this dietary adaptation, we generated a haplotype-resolved …
Heterologous Expression of Recombinant Human Cytochrome P450 (CYP) in Escherichia coli: N-Terminal Modification, Expression, Isolation, Purification, and …
Cytochrome P450 (CYP) enzymes play important roles in metabolising endogenous and
xenobiotic substances. Characterisations of human CYP proteins have been advanced with …
xenobiotic substances. Characterisations of human CYP proteins have been advanced with …
Association of physical activity with bioactive lipids and cardiovascular events
Background: To clarify the mechanisms underlying physical activity (PA)-related
cardioprotection, we examined the association of PA with plasma bioactive lipids (BALs) and …
cardioprotection, we examined the association of PA with plasma bioactive lipids (BALs) and …
Downregulation of CYP39A1 serves as a novel biomarker in hepatocellular carcinoma with worse clinical outcome
D Li, T Yu, J Hu, J Wu, S Feng, Q Xu… - Oxidative Medicine …, 2021 - Wiley Online Library
Background. CYP39A1 is a poorly characterized metabolic enzyme that has been
investigated in a few tumors. However, the role of CYP39A1 in hepatocellular carcinoma …
investigated in a few tumors. However, the role of CYP39A1 in hepatocellular carcinoma …
Oncogenomics and CYP450 Implications in Personalized Cancer Therapy
GK Udayaraja, IA Emerson - Current Pharmacogenomics and …, 2020 - ingentaconnect.com
Background: The Human Genome Project has unleashed the power of genomics in clinical
practice as a choice of individualized therapy, particularly in cancer treatment …
practice as a choice of individualized therapy, particularly in cancer treatment …
[引用][C] Heterologous Expression of Recombinant Human Cytochrome P450 (CYP) in Escherichia coli: N-Terminal Modification, Expression, Isolation, Purification, and …
Cytochrome P450 (CYP) enzymes play important roles in metabolising endogenous and
xenobiotic substances. Characterisations of human CYP proteins have been advanced with …
xenobiotic substances. Characterisations of human CYP proteins have been advanced with …